<
![]( "cervical-cancer-<a href=")
vaccine" src="http://cancer-centre.com/wp-content/uploads/2009/12/cervical-cancer-vaccine.jpg" alt="cervical-cancer-vaccine" width="240" height="192" />The World Health Organization has approved the use of a new vaccine against cervical cancer. This was announced in a statement the company developing the vaccine, GlaxoSmithKline PLC. The name of the new remedy is Cervarix.
Because of this approval, the medical authorities expect to have two vaccines for cervical cancer, may be more easily reached poor countries. He previously had the vaccine called Gardasil, manufactured by Merck & Co. But the price of about $ 360 for three applications is too expensive for the populations of poor countries.
Urge lower the cost of this vaccine to learn that 80 percent of the 280 thousand deaths arising from cervical cancer occur in third world countries.
So far
no Cervarix has been approved for use in countries like the U.S. where Gardasiul has a monopoly, and Japan. However, it has authorization in 97 other nations.
Authorities of the Global Alliance for Vaccines and Immunization have put their hopes that having two competitors in the market are cheaper and the drug costs more easily able to reach patients in poor countries.
Leave a Reply